Mark D. Kaufmann, MD, FAAD
SESSIONS
No sessions scheduled for this speaker.
DISCLOSURES
Apogee Therapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Dermagnostix – Consultant (1099 relationship)(Fees); Dermsquared – Other(Fees); DermTech Inc. – Consultant (1099 relationship)(Fees); Incyte – Consultant (1099 relationship)(Fees); Modernizing Medicine – Consultant(Stock); MoleSafe, Inc. – Other(Stock); Novan – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); Rise Healthcare Tech, Inc. – Advisory Board(Stock Options); Rivera Consulting – Consultant (1099 relationship)(Fees); ROM Technologies Inc. – Consultant (1099 relationship)(Stock); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees);